{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:24:43Z","timestamp":1789457083702,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["HHSN268200900046C"],"award-info":[{"award-number":["HHSN268200900046C"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["A-HL-13-002-001"],"award-info":[{"award-number":["A-HL-13-002-001"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["I4EIA18560026"],"award-info":[{"award-number":["I4EIA18560026"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2 CX002105"],"award-info":[{"award-number":["IK2 CX002105"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK098234"],"award-info":[{"award-number":["R01DK098234"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015728","name":"Clinical Science Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.xkme.2025.101024","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:41:55Z","timestamp":1747251715000},"page":"101024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of Plasma KIM-1, TNFR-1, and TNFR-2 With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Chronic Kidney Disease: An Ancillary Analysis of SPRINT"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-1152","authenticated-orcid":false,"given":"Nicholas","family":"Wettersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon B.","family":"Ascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa K.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav S.","family":"Garimella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xkme.2025.101024_bib1","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.xkme.2025.101024_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"9731","key":"10.1016\/j.xkme.2025.101024_bib3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.xkme.2025.101024_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: Pathophysiological Insights and Therapeutic Options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.xkme.2025.101024_bib5","series-title":"System USRD. 2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2023"},{"issue":"9","key":"10.1016\/j.xkme.2025.101024_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101024_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: a route to targeted therapies","volume":"14","author":"Ruparelia","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.xkme.2025.101024_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2023.02.031","article-title":"Association of kidney tubule biomarkers with cardiac structure and function in the multiethnic study of atherosclerosis","volume":"196","author":"Wettersten","year":"2023","journal-title":"Am J Cardiol"},{"issue":"42","key":"10.1016\/j.xkme.2025.101024_bib9","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1093\/eurheartj\/ehz392","article-title":"Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the Sprint trial","volume":"40","author":"Garimella","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.xkme.2025.101024_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","article-title":"The promise of tubule biomarkers in kidney disease: a review","volume":"78","author":"Ix","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.xkme.2025.101024_bib11","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.xkme.2025.101024_bib13","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1681\/ASN.2016101101","article-title":"Plasma biomarkers and kidney function decline in early and established diabetic kidney disease","volume":"28","author":"Coca","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101024_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.08780621","article-title":"Association between TNF receptors and KIM-1 with kidney outcomes in early-stage diabetic kidney disease","volume":"17","author":"Waijer","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1681\/ASN.2020040487","article-title":"Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"32","author":"Schrauben","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101024_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2021.09.018","article-title":"Associations of plasma biomarkers of inflammation, fibrosis, and kidney tubular injury with progression of diabetic kidney disease: A cohort study","volume":"79","author":"Guti\u00e9rrez","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2020.11.014","article-title":"Biomarkers of immune activation and incident kidney failure with replacement therapy: findings from the African American study of kidney disease and hypertension","volume":"78","author":"Chen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101024_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.ajkd.2021.05.013","article-title":"Plasma kidney injury Molecule 1 in CKD: findings from the Boston Kidney biopsy cohort and CRIC studies","volume":"79","author":"Schmidt","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2025.101024_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1681\/ASN.2021111453","article-title":"Acute kidney injury associates with long-term increases in plasma TNFR1, TNFR2, and KIM-1: findings from the CRIC study","volume":"33","author":"McCoy","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101024_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ekir.2020.12.025","article-title":"The associations of plasma biomarkers of inflammation with histopathologic lesions, kidney disease progression, and mortality-the Boston Kidney biopsy cohort study","volume":"6","author":"Srivastava","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.xkme.2025.101024_bib21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1681\/ASN.2021060735","article-title":"Longitudinal TNFR1 and TNFR2 and kidney outcomes: results from AASK and VA NEPHRON-D","volume":"33","author":"Chen","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101024_bib22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.kint.2020.06.037","article-title":"Results from the TRIBE-AKI Study found associations between post-operative blood biomarkers and risk of chronic kidney disease after cardiac surgery","volume":"99","author":"Menez","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13019-022-02066-4","article-title":"Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study","volume":"17","author":"Vasquez-Rios","year":"2022","journal-title":"J Cardiothorac Surg"},{"issue":"22","key":"10.1016\/j.xkme.2025.101024_bib24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2025.101024_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic blood pressure Intervention Trial (Sprint)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.xkme.2025.101024_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ndt\/gfl744","article-title":"Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study","volume":"22","author":"Singh","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2025.101024_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.xkme.2025.101024_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585880","article-title":"Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects","volume":"11","author":"Gough","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.xkme.2025.101024_bib30","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02670316","article-title":"The associations of blood kidney injury Molecule-1 and neutrophil gelatinase\u2013associated lipocalin with progression from CKD to ESRD","volume":"11","author":"Alderson","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-016-0359-8","article-title":"Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes","volume":"15","author":"Carlsson","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"19","key":"10.1016\/j.xkme.2025.101024_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006666","article-title":"Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease","volume":"96","author":"Bae","year":"2017","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.xkme.2025.101024_bib33","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc13-2580","article-title":"Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the surdiagene cohort","volume":"37","author":"Saulnier","year":"2014","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.xkme.2025.101024_bib34","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.xkme.2025.101024_bib35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/infdis\/jiac186","article-title":"Systemic inflammation is associated with future risk of fatal infection: an observational cohort study","volume":"226","author":"Drozd","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.xkme.2025.101024_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/aje\/kwr085","article-title":"Inflammation biomarkers and risk of all-cause mortality in the reasons for geographic and racial differences in stroke cohort","volume":"174","author":"Kabagambe","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.xkme.2025.101024_bib37","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/ijms20071698","article-title":"Cross-talk between neurohormonal pathways and the immune system in heart failure: a review of the literature","volume":"20","author":"De Angelis","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.xkme.2025.101024_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xkme.2025.101024_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"25","key":"10.1016\/j.xkme.2025.101024_bib41","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"issue":"28","key":"10.1016\/j.xkme.2025.101024_bib42","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.xkme.2025.101024_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:23:06Z","timestamp":1778523786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2590059525000603"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101024","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Plasma KIM-1, TNFR-1, and TNFR-2 With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Chronic Kidney Disease: An Ancillary Analysis of SPRINT","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}],"article-number":"101024"}}